Evidence-Based Medicine Guidelines
Topical antifungals for seborrhoeic dermatitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Topical Antifungals for Seborrhoeic Dermatitis." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458526/all/Topical_antifungals_for_seborrhoeic_dermatitis.
Topical antifungals for seborrhoeic dermatitis. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/458526/all/Topical_antifungals_for_seborrhoeic_dermatitis. Accessed March 27, 2025.
Topical antifungals for seborrhoeic dermatitis. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/458526/all/Topical_antifungals_for_seborrhoeic_dermatitis
Topical Antifungals for Seborrhoeic Dermatitis [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458526/all/Topical_antifungals_for_seborrhoeic_dermatitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Topical antifungals for seborrhoeic dermatitis
ID - 458526
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458526/all/Topical_antifungals_for_seborrhoeic_dermatitis
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
